Advertisement
Screener

SCPHARMACEUTICALS INC. Research and Development Expense

SCPHARMACEUTICALS INC. Research and Development Expense

SCPHARMACEUTICALS INC. reported Research and Development Expense of $4.10 million for the 3-month period ending 2025-06-30, per its 10-Q filed 2025-08-07.

Financial Statements › Expense Statement › Operating Expenses

us-gaap:ResearchAndDevelopmentExpense · last filed 2025-08-07

  • SCPHARMACEUTICALS INC. research and development expense for the quarter ending 2025-06-30 was $4.10M, a 53.08% increase year-over-year.
  • SCPHARMACEUTICALS INC. research and development expense for the quarter ending 2025-03-31 was $4.63M, a 69.88% increase year-over-year.
  • SCPHARMACEUTICALS INC. research and development expense for the quarter ending 2024-12-31 was $3.15M, a 5.51% decline year-over-year.
  • SCPHARMACEUTICALS INC. research and development expense for the quarter ending 2024-09-30 was $3.54M, a 3.51% increase year-over-year.
  • SCPHARMACEUTICALS INC. research and development expense for fiscal 2024 was $12.10M, a 2.45% increase from fiscal 2023.
  • SCPHARMACEUTICALS INC. research and development expense for fiscal 2023 was $11.81M, a 23.97% decline from fiscal 2022.
  • SCPHARMACEUTICALS INC. research and development expense for fiscal 2022 was $15.53M, a 3.15% decline from fiscal 2021.
  • SCPHARMACEUTICALS INC. research and development expense for fiscal 2021 was $16.04M, a 11.63% decline from fiscal 2020.
Period endResearch and Development Expense 3 monthResearch and Development Expense 6 monthResearch and Development Expense 9 monthResearch and Development Expense 12 month
2025-06-30$4.10M
10-Q · filed 2025-08-07
$8.73M
10-Q · filed 2025-08-07
$11.88M
derived: sum of 3 quarters · filed 2025-08-07
$15.42M
derived: sum of 4 quarters · filed 2025-08-07
2025-03-31$4.63M
10-Q · filed 2025-05-14
$7.79M
derived: sum of 2 quarters · filed 2025-05-14
$11.33M
derived: sum of 3 quarters · filed 2025-05-14
$14.00M
derived: sum of 4 quarters · filed 2025-08-07
2024-12-31$3.15M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-19
$6.70M
derived: sum of 2 quarters · filed 2025-03-19
$9.37M
derived: sum of 3 quarters · filed 2025-08-07
$12.10M
10-K · filed 2025-03-19
2024-09-30$3.54M
10-Q · filed 2024-11-13
$6.22M
derived: sum of 2 quarters · filed 2025-08-07
$8.94M
10-Q · filed 2024-11-13
$12.28M
derived: sum of 4 quarters · filed 2025-08-07
2024-06-30$2.68M
10-Q · filed 2025-08-07
$5.40M
10-Q · filed 2025-08-07
$8.74M
derived: sum of 3 quarters · filed 2025-08-07
$12.16M
derived: sum of 4 quarters · filed 2025-08-07
2024-03-31$2.73M
10-Q · filed 2025-05-14
$6.06M
derived: sum of 2 quarters · filed 2025-05-14
$9.48M
derived: sum of 3 quarters · filed 2025-05-14
$12.42M
derived: sum of 4 quarters · filed 2025-05-14
2023-12-31$3.34M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-19
$6.76M
derived: sum of 2 quarters · filed 2025-03-19
$9.69M
derived: sum of 3 quarters · filed 2025-03-19
$11.81M
10-K · filed 2025-03-19
2023-09-30$3.42M
10-Q · filed 2024-11-13
$6.36M
derived: sum of 2 quarters · filed 2024-11-13
$8.47M
10-Q · filed 2024-11-13
$10.80M
derived: sum of 4 quarters · filed 2024-11-13
2023-06-30$2.93M
10-Q · filed 2024-08-14
$5.05M
10-Q · filed 2024-08-14
$7.38M
derived: sum of 3 quarters · filed 2024-08-14
$11.09M
derived: sum of 4 quarters · filed 2024-08-14
2023-03-31$2.12M
10-Q · filed 2024-05-14
$4.44M
derived: sum of 2 quarters · filed 2024-05-14
$8.16M
derived: sum of 3 quarters · filed 2024-05-14
$13.30M
derived: sum of 4 quarters · filed 2024-05-14
2022-12-31$2.33M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13
$6.04M
derived: sum of 2 quarters · filed 2024-03-13
$11.19M
derived: sum of 3 quarters · filed 2024-03-13
$15.53M
10-K · filed 2024-03-13
2022-09-30$3.72M
10-Q · filed 2023-11-08
$8.86M
derived: sum of 2 quarters · filed 2023-11-08
$13.21M
10-Q · filed 2023-11-08
$17.74M
derived: sum of 4 quarters · filed 2023-11-08
2022-06-30$5.14M
10-Q · filed 2023-08-10
$9.49M
10-Q · filed 2023-08-10
$14.02M
derived: sum of 3 quarters · filed 2023-08-10
$17.71M
derived: sum of 4 quarters · filed 2023-08-10
2022-03-31$4.35M
10-Q · filed 2023-05-10
$8.88M
derived: sum of 2 quarters · filed 2023-05-10
$12.57M
derived: sum of 3 quarters · filed 2023-05-10
$16.38M
derived: sum of 4 quarters · filed 2023-05-10
2021-12-31$4.53M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22
$8.22M
derived: sum of 2 quarters · filed 2023-03-22
$12.03M
derived: sum of 3 quarters · filed 2023-03-22
$16.04M
10-K · filed 2023-03-22
2021-09-30$3.69M
10-Q · filed 2022-11-09
$7.50M
derived: sum of 2 quarters · filed 2022-11-09
$11.51M
10-Q · filed 2022-11-09
$15.26M
derived: sum of 4 quarters · filed 2022-11-09
2021-06-30$3.81M
10-Q · filed 2022-08-09
$7.82M
10-Q · filed 2022-08-09
$11.56M
derived: sum of 3 quarters · filed 2022-08-09
$16.68M
derived: sum of 4 quarters · filed 2022-08-09
2021-03-31$4.01M
10-Q · filed 2022-05-16
$7.75M
derived: sum of 2 quarters · filed 2022-05-16
$12.87M
derived: sum of 3 quarters · filed 2022-05-16
$18.01M
derived: sum of 4 quarters · filed 2022-05-16
2020-12-31$3.75M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-22
$8.86M
derived: sum of 2 quarters · filed 2022-03-22
$14.00M
derived: sum of 3 quarters · filed 2022-03-22
$18.15M
10-K · filed 2022-03-22
2020-09-30$5.12M
10-Q · filed 2021-11-09
$10.26M
derived: sum of 2 quarters · filed 2021-11-09
$14.40M
10-Q · filed 2021-11-09
$22.72M
derived: sum of 4 quarters · filed 2021-11-09
2020-06-30$5.14M
10-Q · filed 2021-08-11
$9.29M
10-Q · filed 2021-08-11
$17.60M
derived: sum of 3 quarters · filed 2021-08-11
$21.90M
derived: sum of 4 quarters · filed 2021-08-11
2020-03-31$4.15M
10-Q · filed 2021-05-12
$12.46M
derived: sum of 2 quarters · filed 2021-05-12
$16.76M
derived: sum of 3 quarters · filed 2021-05-12
$22.25M
derived: sum of 4 quarters · filed 2021-05-12
2019-12-31$8.32M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-23
$12.61M
derived: sum of 2 quarters · filed 2021-03-23
$18.11M
derived: sum of 3 quarters · filed 2021-03-23
$24.63M
10-K · filed 2021-03-23
2019-09-30$4.29M
10-Q · filed 2020-11-16
$9.79M
derived: sum of 2 quarters · filed 2020-11-16
$16.31M
10-Q · filed 2020-11-16
$19.46M
derived: sum of 4 quarters · filed 2020-11-16
2019-06-30$5.50M
10-Q · filed 2020-08-13
$12.02M
10-Q · filed 2020-08-13
$15.17M
derived: sum of 3 quarters · filed 2020-08-13
$19.07M
derived: sum of 4 quarters · filed 2020-08-13
2019-03-31$6.52M
10-Q · filed 2020-05-12
$9.67M
derived: sum of 2 quarters · filed 2020-05-12
$13.57M
derived: sum of 3 quarters · filed 2020-05-12
$18.42M
derived: sum of 4 quarters · filed 2020-05-12
2018-12-31$3.15M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-24
$7.04M
derived: sum of 2 quarters · filed 2020-03-24
$11.90M
derived: sum of 3 quarters · filed 2020-03-24
$15.95M
10-K · filed 2020-03-24
2018-09-30$3.90M
10-Q · filed 2019-11-12
$8.75M
derived: sum of 2 quarters · filed 2019-11-12
$12.80M
10-Q · filed 2019-11-12
$16.52M
derived: sum of 4 quarters · filed 2019-11-12
2018-06-30$4.86M
10-Q · filed 2019-08-07
$8.90M
10-Q · filed 2019-08-07
$12.62M
derived: sum of 3 quarters · filed 2019-08-07
$16.20M
derived: sum of 4 quarters · filed 2019-08-07
2018-03-31$4.05M
10-Q · filed 2019-05-08
$7.76M
derived: sum of 2 quarters · filed 2019-05-08
$11.35M
derived: sum of 3 quarters · filed 2019-05-08
$15.49M
derived: sum of 4 quarters · filed 2019-05-08
2017-12-31$3.72M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-21
$7.30M
derived: sum of 2 quarters · filed 2019-03-21
$11.45M
derived: sum of 3 quarters · filed 2019-03-21
$14.33M
10-K · filed 2019-03-21
2017-09-30$3.58M
10-Q · filed 2018-11-13
$7.73M
derived: sum of 2 quarters · filed 2018-11-13
$10.62M
10-Q · filed 2018-11-13
2017-06-30$4.14M
10-Q · filed 2018-08-14
$7.03M
10-Q · filed 2018-08-14
2017-03-31$2.88M
10-Q · filed 2018-05-07
2016-12-31$11.86M
10-K · filed 2019-03-21